Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia.

Craddock KJ, Chen Y, Brandwein JM, Chang H.

Leuk Res. 2013 Jul;37(7):759-64. doi: 10.1016/j.leukres.2013.04.006. Epub 2013 May 1.

PMID:
23643324
2.

Aberrant expression of CD13 identifies a subgroup of standard-risk adult acute lymphoblastic leukemia with inferior survival.

Dalal BI, Al Mugairi A, Pi S, Lee SY, Khare NS, Pal J, Bryant A, Vakil AP, Lau S, Abou Mourad YR.

Clin Lymphoma Myeloma Leuk. 2014 Jun;14(3):239-44. doi: 10.1016/j.clml.2013.10.003. Epub 2013 Nov 14.

PMID:
24411984
3.

Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.

Plesa C, Chelghoum Y, Plesa A, Elhamri M, Tigaud I, Michallet M, Dumontet C, Thomas X.

Cancer. 2008 Feb 1;112(3):572-80.

4.

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF; PETHEMA Group, Spanish Society of Hematology.

Haematologica. 2002 Feb;87(2):154-66.

5.

[Prognostic factors of adult Philadelphia chromosome negative acute lymphoblastic leukemia].

Wang J, Huang X, Jiang B, Jia J, Yang S, Bao L, Jiang H, Lu J, Zhu H, Zhao T, Jiang Q.

Zhonghua Xue Ye Xue Za Zhi. 2015 Jan;36(1):10-5. doi: 10.3760/cma.j.issn.0253-2727.2015.01.003. Chinese.

PMID:
25641138
6.

Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

Vitale A, Guarini A, Ariola C, Meloni G, Perbellini O, Pizzuti M, De Gregoris C, Mettivier V, Pastorini A, Pizzolo G, Vignetti M, Mandelli F, Foà R.

Haematologica. 2007 Mar;92(3):342-8.

7.

Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.

Thomas X, Danaïla C, Le QH, Sebban C, Troncy J, Charrin C, Lhéritier V, Michallet M, Magaud JP, Fiere D.

Leukemia. 2001 Dec;15(12):1811-22.

PMID:
11753600
8.

Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia.

Chen H, Liu KY, Xu LP, Liu DH, Chen YH, Zhao XY, Han W, Zhang XH, Wang Y, Zhang YY, Qin YZ, Liu YR, Huang XJ.

J Hematol Oncol. 2012 Jun 8;5:29. doi: 10.1186/1756-8722-5-29.

9.

Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).

Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.

Haematologica. 1998 Nov;83(11):967-73.

10.

Prognostic value of cytogenetics in adult patients with Philadelphia-negative acute lymphoblastic leukemia.

Gómez-Seguí I, Cervera J, Such E, Martínez-Cuadrón D, Luna I, Ibáñez M, López-Pavía M, Gascón A, Roig M, Martínez J, Sanz J, Montesinos P, Martín-Aragonés G, Lorenzo I, Senent L, Barragán E, Cordón L, Sempere A, Sanz GF, Sanz MA.

Ann Hematol. 2012 Jan;91(1):19-25. doi: 10.1007/s00277-011-1331-z. Epub 2011 Sep 21.

PMID:
21935650
11.

CD38+ CD58- is an independent adverse prognostic factor in paediatric Philadelphia chromosome negative B cell acute lymphoblastic leukaemia patients.

Li XM, Zhang LP, Wang YZ, Lu AD, Chang Y, Zhu HH, Qin YZ, Lai YY, Kong Y, Huang XJ, Liu YR.

Leuk Res. 2016 Apr;43:33-8. doi: 10.1016/j.leukres.2015.12.015. Epub 2016 Jan 4.

PMID:
26930456
12.

Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis.

Gleissner B, Gökbuget N, Bartram CR, Janssen B, Rieder H, Janssen JW, Fonatsch C, Heyll A, Voliotis D, Beck J, Lipp T, Munzert G, Maurer J, Hoelzer D, Thiel E; German Multicenter Trials of Adult Acute Lymphoblastic Leukemia Study Group.

Blood. 2002 Mar 1;99(5):1536-43.

13.

Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.

Boissel N, Auclerc MF, Lhéritier V, Perel Y, Thomas X, Leblanc T, Rousselot P, Cayuela JM, Gabert J, Fegueux N, Piguet C, Huguet-Rigal F, Berthou C, Boiron JM, Pautas C, Michel G, Fière D, Leverger G, Dombret H, Baruchel A.

J Clin Oncol. 2003 Mar 1;21(5):774-80. Epub 2003 Mar 1.

PMID:
12610173
14.

Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.

Rambaldi A, Attuati V, Bassan R, Neonato MG, Viero P, Battista R, Di Bona E, Rossi G, Pogliani E, Ruggeri M, Amaru R, Rivolta A, Giudici G, Biondi A, Barbui T.

Leuk Lymphoma. 1996 May;21(5-6):457-66.

PMID:
9172811
15.

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission.

Patel B, Kirkland KE, Szydlo R, Pearce RM, Clark RE, Craddock C, Liakopoulou E, Fielding AK, Mackinnon S, Olavarria E, Potter MN, Russell NH, Shaw BE, Cook G, Goldstone AH, Marks DI.

Haematologica. 2009 Oct;94(10):1399-406. doi: 10.3324/haematol.2009.008649. Epub 2009 Jul 31.

16.

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, Chevallier P, Buzyn A, Delannoy A, Chalandon Y, Vernant JP, Lafage-Pochitaloff M, Chassevent A, Lhéritier V, Macintyre E, Béné MC, Ifrah N, Dombret H.

J Clin Oncol. 2009 Feb 20;27(6):911-8. doi: 10.1200/JCO.2008.18.6916. Epub 2009 Jan 5. Erratum in: J Clin Oncol. 2009 May 20;27(15):2574. Dosage error in article text.

PMID:
19124805
17.

Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.

Gaikwad AS, Donohue RE, Elghetany MT, Sheehan AM, Lu XY, Gramatges MM, McClain KL, Mistretta TA, Punia JN, Moore TJ, Goltsova T, Cubbage M, Curry CV.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6225-30. eCollection 2014.

18.

Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).

Wrzesień-Kuś A, Robak T, Pluta A, Zwolińska M, Wawrzyniak E, Wierzbowska A, Skotnicki A, Jakubas B, Hołowiecki J, Nowak K, Kuliczkowski K, Mazur G, Haus O, Dmoszyńska A, Adamczyk-Cioch M, Jedrzejczak WW, Paluszewska M, Konopka L, Pałynyczko G.

Ann Hematol. 2006 Jun;85(6):366-73. Epub 2006 Mar 8.

PMID:
16523310
19.

High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia.

Mu Q, Wang Y, Chen B, Qian W, Meng H, Tong H, Chen F, Ma Q, Ni W, Chen S, Jin J.

Leuk Res. 2013 Aug;37(8):922-7. doi: 10.1016/j.leukres.2013.05.012. Epub 2013 Jun 4.

PMID:
23759245
20.

Phosphorylated CXCR4 is associated with poor survival in adults with B-acute lymphoblastic leukemia.

Konoplev S, Jorgensen JL, Thomas DA, Lin E, Burger J, Kantarjian HM, Andreeff M, Medeiros LJ, Konopleva M.

Cancer. 2011 Oct 15;117(20):4689-95. doi: 10.1002/cncr.26113. Epub 2011 Mar 31.

Supplemental Content

Support Center